ImmunoPrecise to Lead Scientific Round-table Discussion
At hubXchange's European Antibody Therapeutics event, Debby Kruijsen will lead a round-table discussion entitled 'Implementing...
ImmunoPrecise to Exhibit at the PEGS Summit, US
ImmunoPrecise has announced it will be exhibiting at the upcoming PEGS Summit conference in Boston, Massachusetts, US.
Taking place from 30 April to 4 May, the convention will be hosted at the Seaport World Trade Center.
ImmunoPrecise welcomes you to come and say hello to its team at booth 618. The company’s team members that will be attending are:
- CEO Jennifer Bath
- Chief scientific officer Deanna Dryhurst
- Director of molecular services Andra Li
- Director of hybridoma services David Kroeger
- Vice-president of sales and support services Teri Otto
ImmunoPrecise will be demonstrating featured services, including:
- Rabbit monoclonals
- Hybridoma development
- Human monoclonals
- Protein expression
- Cryostorage
- Antibody expression
PEGS Boston information
PEGS Boston features nearly 400 presentations by world renowned leaders from pharmaceutical, academia, and government, showcasing case studies, cutting-edge data, insight and perspective.
Conference programmes include a broad spectrum of topics including protein and antibody engineering, cancer immunotherapy, oncology and emerging therapeutics.
More About This Company
Second US Office for ImmunoPrecise Antibodies in Massachusetts
Immunoprecise Antibodies has announced that it has opened a new subsidiary office in Cambridge, Massachusetts,...
ImmunoPrecise Increases Private Placement to $0.80 per Unit
ImmunoPrecise Antibodies has increased its non-brokered private placement financing to 875,000 units of ImmunoPrecise at...